English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 12145/12927 (94%)
造访人次 : 914541      在线人数 : 1368
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧:
  • 您可在西文检索词汇前后加上"双引号",以获取较精准的检索结果
  • 若欲以作者姓名搜寻,建议至进阶搜寻限定作者字段,可获得较完整数据
  • 进阶搜寻
    主页登入上传说明关于NHRI管理 到手机版

    子类别

    期刊論文 [100/101]
    會議論文/會議摘要 [19/24]

    社群统计


    近3年内发表的文件:16(12.80%)
    含全文笔数:119(95.20%)

    文件下载次数统计
    下载大于0次:119(100.00%)
    下载大于100次:115(96.64%)
    全文下载总次数:64444(1.20%)

    最后更新时间: 2024-12-01 08:32

    上传排行

    数据加载中.....

    下载排行

    数据加载中.....

    RSS Feed RSS Feed
    跳至:
    或输入年份:
    由新到旧排序 由最旧的开始

    显示项目51-75 / 125. (共5页)
    << < 1 2 3 4 5 > >>
    每页显示[10|25|50]项目

    日期题名關聯
    2016-12 Glucocorticoids may compromise the effect of gefitinib in non-small cell lung cancer Oncotarget. 2016 Dec;7(52):85917-85928.
    2016-10-01 The prognostic impact of overall treatment time on disease outcomes of uterine cervical cancer patients: A nationwide cohort study of Taiwan International Journal of Radiation Oncology, Biology, Physics. 2016 Oct 1;96(2S, Suppl.):E301.
    2016-10-01 The influence of hospital volume on disease outcomes of advanced uterine cervical cancer patients: A nationwide cohort study of Taiwan International Journal of Radiation Oncology, Biology, Physics. 2016 Oct 1;96(2S, Suppl.):S15-S16.
    2016-10 The role of pre-treatment plasma Epstein-Barr virus (EBV) DNA as a predictive biomarker of induction chemotherapy for stage IVA or IVB nasopharyngeal carcinoma (NPC) patients - A Subgroup Analysis on Taiwan Cooperative Oncology Group (TCOG) 1303 study Annals of Oncology. 2016 Oct;27(Suppl.6 ):Meeting Abstract 973P.
    2016-09 Trend in and correlates of undergoing radiotherapy in Taiwanese cancer patients' last month of life Journal of Pain and Symptom Management. 2016 Sep;52(3):395-403.
    2016-08 Characteristics and correlates of increasing use of surgery in Taiwanese cancer patients' last month of life, 2001-2010 Annals of Surgery. 2016 Aug;264(2):283-290.
    2016-07 Characteristics of young lung cancer: Analysis of Taiwan's nationwide lung cancer registry focusing on epidermal growth factor receptor mutation and smoking status Oncotarget. 2016 Aug;7(29):46628-46635.
    2016-04 Receipt of life-sustaining treatments for Taiwanese pediatric patients who died of cancer in 2001 to 2010: A retrospective cohort study Medicine. 2016 Apr;95(16):Article number e3461.
    2016-01 S-1 with leucovorin for gastric cancer: How far can it go? Lancet Oncology. 2016 Jan;17(1):12-14.
    2016-01 A phase II study of sequential capecitabine plus oxaliplatin followed by docetaxel plus capecitabine in patients with unresectable gastric adenocarcinoma: The TCOG 3211 clinical trial Medicine. 2016 Jan;95(3):Article number e2565.
    2015-12 Breast cancer quality of care in Taiwan in relation to hospital volume: A population-based cohort study Asia-Pacific Journal of Clinical Oncology. 2015 Dec;11(4):308-313.
    2015-12 A decade of changes in preferences for life-sustaining treatments among terminally Ill patients with cancer Journal of the National Comprehensive Cancer Network. 2015 Dec;13(12):1510-1518.
    2015-12 A phase II study of sequential capecitabine plus oxaliplatin (XELOX) followed by docetaxel plus capecitabine (TX) in patients with unresectable gastric adenocarcinoma-TCOG 3211 clinical trial Journal of Gastroenterology and Hepatology. 2015 Dec;30(Suppl. S4):99.
    2015-11 Determinants of hospital death for Taiwanese pediatric cancer decedents, 2001–2010 Journal of Pain and Symptom Management. 2015 Nov;50(5):685-692.
    2015-08 Increasing receipt of high-tech/high-cost imaging and its determinants in the last month of Taiwanese patients with metastatic cancer, 2001-2010: A retrospective cohort study Medicine. 2015 Aug;94(32):Article number e1354.
    2015-05 Preferences for aggressive end-of-life care and their determinants among Taiwanese terminally Ill cancer patients Cancer Nursing. 2015 May;38(3):E9-E18.
    2015-05 A phase II study of sequential capecitabine plus oxaliplatin (XELOX) followed by docetaxel plus capecitabine (TX) in patients with unresectable gastric adenocarcinoma: The TCOG T3211 trial Journal of Clinical Oncology. 2015 May;33(15, Suppl.):4024.
    2015-04 Perfusion parameters of dynamic contrast-enhanced magnetic resonance imaging predict outcomes of hepatocellular carcinoma receiving radiotherapy with or without thalidomide Hepatology International. 2015 Apr;9(2):258-268.
    2015-04 Long-term outcome of chemotherapy-induced HBV reactivation in lymphoma patients with resolved HBV infection Journal of Hepatology. 2015 Apr;62, Suppl. 2:S563.
    2014-12 Physician-patient end-of-life care discussions: Correlates and associations with end-of-life care preferences of cancer patients-a cross-sectional survey study Palliative Medicine. 2014 Dec;28(10):1222-1230.
    2014-07 Associations between accurate prognostic understanding and end-of-life care preferences and its correlates among Taiwanese terminally ill cancer patients surveyed in 2011–2012 Psycho-Oncology. 2014 Jul;23(7):780-787.
    2014-06 Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: A prospective study Hepatology. 2014 Jun; 59(6):2092-2100
    2014-05 Celecoxib plus chemoradiotherapy for locally advanced rectal cancer: A phase II TCOG study Journal of Surgical Oncology. 2014 May;109(6):580-585.
    2012-10 Development and validation of an instrument for the measurement of Health-Related Quality of Life Based on View of Traditional Chinese Medicine Perspective Journal of Traditional and Complementary Medicine. 2012 Oct;2(4):295-300.
    2012-04 Use of chemotherapy at the end of life among Taiwanese cancer decedents, 2001-2006 Acta Oncologica. 2012 Apr;51(4):505-511.

    显示项目51-75 / 125. (共5页)
    << < 1 2 3 4 5 > >>
    每页显示[10|25|50]项目

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈